Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell–driven B cell responses
Hyung W. Lim, Peter Hillsamer, Chang H. Kim
Hyung W. Lim, Peter Hillsamer, Chang H. Kim
View: Text | PDF | Erratum
Article Immunology

Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell–driven B cell responses

  • Text
  • PDF
Abstract

How Tregs migrate to GCs, and whether they regulate the helper activity of the T cells in GCs (GC-Th cells) remains poorly understood. We found a T cell subset in human tonsils that displays potent suppressive activities toward GC-Th cell–dependent B cell responses. These Tregs with the surface phenotype of CD4+CD25+CD69– migrate well to CCL19, a chemokine expressed in the T cell zone, but poorly to CXCL13, a chemokine expressed in the B cell zone. This migration toward the T cell–rich zone rapidly changes to trafficking toward B cell follicles upon T cell activation. This change in chemotactic behavior upon activation of T cells is consistent with their switch in the expression of the 2 chemokine receptors CXCR5 and CCR7. CD4+CD25+CD69– Tregs suppress GC-Th cells and GC-Th cell–induced B cell responses such as Ig production, survival, and expression of activation-induced cytosine deaminase. Our results have identified a subset of Tregs that is physiologically relevant to GC-Th cell–dependent B cell responses and a potential regulation mechanism for the trafficking of these Tregs to GCs.

Authors

Hyung W. Lim, Peter Hillsamer, Chang H. Kim

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Chemotaxis assay. (A) Chemotactic behaviors of CD4+CD25+CD69– Tregs and ...
Chemotaxis assay. (A) Chemotactic behaviors of CD4+CD25+CD69– Tregs and CD4+CD25+CD69+ T cells. (B) CD4+CD25+CD69– Tregs poorly migrate to CCL1. Fresh tonsil mononuclear cells were used as input cells for chemotaxis assays. Indicated chemokines were first titrated to determine optimal concentrations: CXCL13 (4,000 ng/ml), CXCL12 (100 ng/ml), CXCL10 (1,000 ng/ml), CCL19 (2,000 ng/ml), CCL17 (200 ng/ml), CCL4 (100 ng/ml), and CCL1 (500 ng/ml). Cells were allowed to migrate for 3 hours. The migrated cells and input cells were harvested, stained for CD4, CD25, and CD69, and counted by a FACSCalibur. Specific migration after subtraction of the background migration is shown. The background migration rates (percent averages and SEM, 3 experiments) for the 4 subsets were 25 ± 2.6 (CD4+CD25–CD69+), 13.4 ± 4.3 (CD4+CD25+CD69+), 6.1 ± 0.4 (CD4+CD25+CD69– Treg), and 7.2 ± 2 (CD4+CD25–CD69–). The averages and SEM of the data obtained from 3 (A) and 4 (B) independent experiments are shown. *Significant differences between the 2 subsets (A) or from CD4+CD25+CD69– Tregs (B). The P values were 0.048 (CXCL13) and 0.015 (CCL19) in A; and 0.046 (CD25+CD69– Treg vs. CD25+CD69+), 0.007 (CD25+CD69– Treg vs. CD25–CD69+), and 0.03 (CD25+CD69– Treg vs. CD25–CD69–) in B.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts